Erste Group Bank Issues Positive Forecast for ISRG Earnings

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Stock analysts at Erste Group Bank raised their FY2026 earnings estimates for shares of Intuitive Surgical in a research report issued to clients and investors on Tuesday, May 12th. Erste Group Bank analyst H. Engel now forecasts that the medical equipment provider will post earnings of $8.61 per share for the year, up from their prior estimate of $8.60. The consensus estimate for Intuitive Surgical’s current full-year earnings is $8.57 per share. Erste Group Bank also issued estimates for Intuitive Surgical’s FY2027 earnings at $9.86 EPS.

Other equities research analysts also recently issued research reports about the stock. Truist Financial cut their target price on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Leerink Partners cut their target price on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. cut their target price on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Thursday, April 23rd. Finally, Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $581.91.

Intuitive Surgical Trading Down 1.0%

NASDAQ:ISRG opened at $428.06 on Friday. Intuitive Surgical has a 12 month low of $417.74 and a 12 month high of $603.88. The company has a market cap of $151.60 billion, a PE ratio of 51.89, a price-to-earnings-growth ratio of 3.45 and a beta of 1.51. The company has a 50 day simple moving average of $465.23 and a two-hundred day simple moving average of $514.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the previous year, the firm posted $1.81 EPS. The firm’s revenue was up 23.0% on a year-over-year basis.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the sale, the director directly owned 120 shares in the company, valued at $55,620. This represents a 49.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the sale, the executive vice president owned 6,120 shares of the company’s stock, valued at $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 5,647 shares of company stock worth $2,760,359 over the last three months. 0.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of ISRG. Norges Bank bought a new position in Intuitive Surgical in the 4th quarter worth $2,856,987,000. J. Stern & Co. LLP boosted its holdings in Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after buying an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in Intuitive Surgical by 1,043.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after buying an additional 1,224,734 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares during the period. Finally, Rakuten Investment Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth $388,436,000. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.